GB9817055D0 - Reverse transcription and amplification processes and primers therefore - Google Patents

Reverse transcription and amplification processes and primers therefore

Info

Publication number
GB9817055D0
GB9817055D0 GBGB9817055.8A GB9817055A GB9817055D0 GB 9817055 D0 GB9817055 D0 GB 9817055D0 GB 9817055 A GB9817055 A GB 9817055A GB 9817055 D0 GB9817055 D0 GB 9817055D0
Authority
GB
United Kingdom
Prior art keywords
primers
reverse transcription
amplification processes
amplification
processes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9817055.8A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medical Research Council
Original Assignee
Medical Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medical Research Council filed Critical Medical Research Council
Priority to GBGB9817055.8A priority Critical patent/GB9817055D0/en
Publication of GB9817055D0 publication Critical patent/GB9817055D0/en
Priority to AU52943/99A priority patent/AU5294399A/en
Priority to PCT/GB1999/002579 priority patent/WO2000008208A2/fr
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6853—Nucleic acid amplification reactions using modified primers or templates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
GBGB9817055.8A 1998-08-05 1998-08-05 Reverse transcription and amplification processes and primers therefore Ceased GB9817055D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB9817055.8A GB9817055D0 (en) 1998-08-05 1998-08-05 Reverse transcription and amplification processes and primers therefore
AU52943/99A AU5294399A (en) 1998-08-05 1999-08-05 Reverse transcription and amplification processes and primers therefor
PCT/GB1999/002579 WO2000008208A2 (fr) 1998-08-05 1999-08-05 Transcription inverse, amplification, et leurs amorces

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9817055.8A GB9817055D0 (en) 1998-08-05 1998-08-05 Reverse transcription and amplification processes and primers therefore

Publications (1)

Publication Number Publication Date
GB9817055D0 true GB9817055D0 (en) 1998-09-30

Family

ID=10836764

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9817055.8A Ceased GB9817055D0 (en) 1998-08-05 1998-08-05 Reverse transcription and amplification processes and primers therefore

Country Status (3)

Country Link
AU (1) AU5294399A (fr)
GB (1) GB9817055D0 (fr)
WO (1) WO2000008208A2 (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20020034161A (ko) * 1999-07-19 2002-05-08 알. 씨. 제닝스 불충분한 핵산 서열의 증폭방법 및 그 방법의 수행장치
US6692918B2 (en) * 1999-09-13 2004-02-17 Nugen Technologies, Inc. Methods and compositions for linear isothermal amplification of polynucleotide sequences
US7846733B2 (en) 2000-06-26 2010-12-07 Nugen Technologies, Inc. Methods and compositions for transcription-based nucleic acid amplification
EP1348762B1 (fr) * 2000-12-12 2010-01-27 National Institute of Radiological Sciences Methode d'analyse d'expression genique
DE60142709D1 (de) 2000-12-13 2010-09-09 Nugen Technologies Inc Methoden und zusammensetzungen zur generierung einer vielzahl von kopien von nukleinsäuresequenzen und methoden zur detektion derselben
WO2002072772A2 (fr) 2001-03-09 2002-09-19 Nugen Technologies, Inc. Procedes et compositions permettant l'amplification de sequences d'arn
EP1275738A1 (fr) * 2001-07-11 2003-01-15 Roche Diagnostics GmbH Procédé pour la synthèse aléatoire et l'amplification d'ADNc
DE60234369D1 (de) * 2001-09-19 2009-12-24 Alexion Pharma Inc Manipulierte matrizen und ihre verwendung bei der single-primer-amplifikation
US7414111B2 (en) 2001-09-19 2008-08-19 Alexion Pharmaceuticals, Inc. Engineered templates and their use in single primer amplification
CA2478875A1 (fr) 2002-03-11 2003-09-25 Nugen Technologies, Inc. Procedes d'obtention d'adn a double brin comprenant une portion 3' a simple brin, et utilisation de ces complexes a des fins de recombinaison
GB0216026D0 (en) * 2002-07-10 2002-08-21 Cambridge Biotechnology Ltd Nucleic acid amplification method
JP2006523465A (ja) 2003-04-14 2006-10-19 ニューゲン テクノロジーズ， インコーポレイテッド ランダムにプライミングされる複合プライマーを用いる大規模増幅
CA2552007A1 (fr) 2003-12-29 2005-07-21 Nugen Technologies, Inc. Methodes permettant d'analyser l'etat de methylation d'acides nucleiques et methodes permettant de fragmenter, de marquer et d'immobiliser des acides nucleiques
CA2621267A1 (fr) 2005-09-07 2007-03-15 Nugen Technologies, Inc. Procedure d'amplication d'acide nucleique amelioree
US20090203531A1 (en) 2008-02-12 2009-08-13 Nurith Kurn Method for Archiving and Clonal Expansion
GB2470672B (en) 2008-03-21 2012-09-12 Nugen Technologies Inc Methods of RNA amplification in the presence of DNA
US9206418B2 (en) 2011-10-19 2015-12-08 Nugen Technologies, Inc. Compositions and methods for directional nucleic acid amplification and sequencing
CA2862552A1 (fr) 2012-01-26 2013-08-01 Nugen Technologies, Inc. Compositions et procedes pour l'enrichissement en sequence d'acide nucleique ciblee et la generation d'une banque a efficacite elevee
CN104619894B (zh) 2012-06-18 2017-06-06 纽亘技术公司 用于非期望核酸序列的阴性选择的组合物和方法
US20150011396A1 (en) 2012-07-09 2015-01-08 Benjamin G. Schroeder Methods for creating directional bisulfite-converted nucleic acid libraries for next generation sequencing
US9822408B2 (en) 2013-03-15 2017-11-21 Nugen Technologies, Inc. Sequential sequencing
WO2015073711A1 (fr) 2013-11-13 2015-05-21 Nugen Technologies, Inc. Compositions et procédés pour l'identification d'une lecture de séquençage en double
US9745614B2 (en) 2014-02-28 2017-08-29 Nugen Technologies, Inc. Reduced representation bisulfite sequencing with diversity adaptors
US10102337B2 (en) 2014-08-06 2018-10-16 Nugen Technologies, Inc. Digital measurements from targeted sequencing
US11099202B2 (en) 2017-10-20 2021-08-24 Tecan Genomics, Inc. Reagent delivery system

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7653691A (en) * 1990-04-05 1991-10-30 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Modified rna template-specific polymerase chain reaction
GB9618050D0 (en) * 1996-08-29 1996-10-09 Cancer Res Campaign Tech Global amplification of nucleic acids

Also Published As

Publication number Publication date
WO2000008208A2 (fr) 2000-02-17
WO2000008208A3 (fr) 2000-05-11
AU5294399A (en) 2000-02-28

Similar Documents

Publication Publication Date Title
GB9817055D0 (en) Reverse transcription and amplification processes and primers therefore
ZA991951B (en) Compound and its use.
ZA200204390B (en) Caspase inhibitors and uses thereof.
EP0674194A3 (fr) Microstructure en silicium et son procédé de fabrication.
ZA972435B (en) Dinucleotide and oligonucleotide analogues.
AU4831399A (en) Leafy cotyledon1 genes and their uses
AU5525998A (en) Target-triggered amplification
IL149641A0 (en) Chemical processes and intermediates
AU2002243386A1 (en) Rf2a and rf2b transcription factors
AU2592299A (en) Sailboats and methods
AUPP807799A0 (en) Polynucleotide and method
AU5571799A (en) Angiogenesis inhibitors and uses thereof
AU2001242801A1 (en) Input method for characters and the like
AU2312500A (en) Cage former and clamp therefor
ZA200110474B (en) Method and device for the continuous of NaAlCl4 or NaFeCl4.
AU7577700A (en) Purification device and purification method
GB9816708D0 (en) Catheters and manufacture
GB2340632B (en) Transcription system
AU5979300A (en) Angiopoietin-6 and uses thereof
GB9807586D0 (en) Enzymes and their use
AU2001262291A1 (en) Enzymatic oxidation composition and process
AU4318699A (en) Plant retroelements and methods related thereto
AU3086200A (en) Eyesight-correction and/or eye-training device
AU1106800A (en) Anti-mitotic agents and processes
AU2694200A (en) Itchiness-relieving agents and itchiness-relieving effect potentiators

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)